Ledger.Open graph →
SEC Form D · filed August 17, 2022

SYNTIS BIO, INC

Offering
$11.2M
Sold
$11.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MILTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Rahul K. Dhanda · MILTON, MAExec · DirectorCarlo G. Traverso · MILTON, MADirectorRobert G. Langer · MILTON, MADirectorJohn Vincent · New York, NYExec · DirectorPrakash L. V · Sydney, Channel IslandsDirectorJoe Gozzi · Agoura Hills, CADirectorJeffrey Hall · London, United KingdomExec · DirectorKarl \. Fuehrer · Hesperange, LuxembourgDirectorGeneral Member MasCap Management, LLC · San Juan, Puerto RicoDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗